Concepedia

Luke Norton

LN

Statistics

Publications

40

Citations

3.2K

H-Index

27

Active since

2001

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

University of Nottingham

Queen's Medical Centre

Texas Diabetes Institute

The University of Texas at San Antonio

Luke Norton is an author at The University of Texas at San Antonio Health Science Center specializing in life sciences, diabetes mellitus, and endocrinology.

ORCID

Publications per year

2001–2023

40

Publications

40

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

Aurora Merovci, Carolina Solis‐Herrera, Giuseppe Daniele et al. · Journal of Clinical Investigation · 2014 · 780 citations · Full text

, , +17

Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30–50% of Filtered Glucose Load in Humans

Muhammad Abdul‐Ghani, Ralph A. DeFronzo, Luke Norton · Diabetes · 2013 · 243 citations · Full text

, , +16

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes

Giuseppe Daniele, Juan Xiong, Carolina Solis‐Herrera et al. · Diabetes Care · 2016 · 210 citations · Full text

, , +17

Lactate Elicits ER-Mitochondrial Mg2+ Dynamics to Integrate Cellular Metabolism

Cassidy C. Daw, R. Karthik, Benjamin T. Enslow et al. · Cell · 2020 · 209 citations · Full text

, , +14

The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function

Xi Chen, Iriscilla Ayala, Chris E. Shannon et al. · Diabetes · 2018 · 145 citations

, , +17

1–5 of 40